This analysis demonstrates how aptamer-based molecular monitors improve preventive care in health systems, indicating earlier disease detection.
Enabling preventive medicine and improving patient care via aptamer-based molecular monitors As health systems put greater focus on preventive, personalized care, Netzahualcóyotl Arroyo-Currás tells us about the broad benefits of Continuous Molecular Monitors (CMMs) in providing insights into biomolecular markers that facilitate early disease detection. Imagine waking up and placing a smart patch on your skin. The patch is an adhesive device embedded with painless, microscopic microneedle sensors. As you go about your day, eating, exercising, working, or studying, the patch quietly monitors your health. But it is not just tracking your steps or heart rate. It analyses a wide range of biomolecular markers in real time. These molecular insights can tell you how your body is doing and whether it’s time to visit your doctor for preventive care. The patch can help detect diseases at their earliest stages, before symptoms appear, when treatment is most effective. It can also help fine-tune medication dosages based on real-time molecular data, maximizing benefits while minimizing side effects. This may sound like science fiction, but it is a future that I believe is rapidly approaching.
No takes yet. Share an insight, caveat, or question.
Netzahualcóyotl Arroyo‐Currás (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: